1 of 5

Long Story Short Episode 75: Hydroxychloroquine Reduces Mortality by 35% in Hospitalized COVID-19 Patients

Hydroxychloroquine Reduces Mortality by 35% in Hospitalized COVID-19 Patients

This study from Belgium demonstrates that the use of standard/low dose hydroxychloroquine and azithromycin (macrolide) in hospitalized COVID-19 patients reduces the risk of mortality by 35%. Let’s review.

Share this Lesson
We use cookies on this site to enhance your user experience. By clicking the Accept button, you agree to us doing so. Read our Privacy Policy ACCEPT